Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).

"Declarations Ethics approvalThe institutional review boards at all participating sites approved the study protocol. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Consent to participateThe requirement for informed consent was waived because the study collected the data from the records of usual clinical practice. Consent for publicationOwing to the anonymous nature of the data, the requirement for informed consent was waived. Competing interestsThe authors have no relevant financial or non-financial interests to declare. Competing interests The authors have no relevant financial or non-financial interests to declare."

"Funding Open Access funding provided by The University of Tokyo. This work was supported by a Grant-in-Aid for Scientific Research from the Practical Research for Innovative Cancer Control of the Japan Agency for Medical Research and Development (AMED) (grant number 15ck0106059h0002)."